Urgent Alert:
Major Catalysts Dead Ahead....

Silicon Valley Targets $3.3 Trillion Health Care Industry

New Research Reveals How Top Venture Capitalists And Tech Heavyweights Plotted The Next Great Tech Takeover

Dear reader, 

The next great tech revolution is running at breakneck speed. 

Allied Market Research just released a report pegging growth at 379%.1

And Silicon Valley and the world’s tech heavyweights are getting in position now. 

Rock Health, a healthcare technology fund, says Venture Capital funding for healthcare tech stood at $1.1 billion in 2011.2 

This year it’s on pace to hit $10.8 billion

That’s an increase of 881%.

But it’s just the start of it all. The big boys have jumped on board too. 

Apple’s CEO said health care innovations will be the company’s “greatest contribution to mankind.”

Google Health now has 500 employees. 

Amazon’s kicked off its Amazon Care program just last year.  

Big changes are coming and the time to move is now. 

Psychedelic Stock Watch has just updated research on the coming tech disruption of healthcare and the early movers behind the soaring growth of “Digital Therapeutics.” 

Enter your email to sign up for latest updates on this red-hot growth sector.

 


BONUS: When you sign up, you’ll also get ongoing research on these and other high-potential opportunities too with Psychedelic Stock Watch. 



1. Allied Market Research
2. Rock Health Research
 
Disclaimer:
Please see our full PRIVACY POLICY

The content on Psychedelic Stock Watch is not personalized investment advice. Our employees strive to give smart, stimulating commentary, but are not licensed to address or give advice on individual investment situations. Nothing you receive from Psychedelic Stock Watch should be considered personal investment advice. Any investments recommended by Psychedelic Stock Watch should only be made after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. All investments carry risk of significant loss.

Please see full disclaimers at https://psychedelicstockwatch.com/ applicable to all content provided by PSW , wherever published or re-published: https://psychedelicstockwatch.com/statements-policies

Disclaimer: This release/advertorial is a commercial advertisement and is for general information purposes only. This release/advertorial does not constitute an offer or solicitation to buy or sell any securities or individualized investment advice. This is a native advertisement, meaning it is an informational paid marketing piece. PsychedelicStockWatch.com (PSW) makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Please review all investment decisions with a licensed investment advisor. PSW receives media support and payments ranging from approximately $25,000 to $150,000 to publish and/or distribute advertisements on behalf of a company. PSW retains any excess sums after expenses as its compensation. PsychedelicStockWatch.com (PSW)  and its owners, operators and affiliates may benefit from any increase in the share prices of the profiled companies. PsychedelicStockWatch.com (PSW) may be paid for services using options or free-trading shares. PsychedelicStockWatch.com (PSW) and/or its owners, operators and affiliates may be selling shares of stock at the same time the profile (or other information) is being disseminated to potential investors; PsychedelicStockWatch.com will not advise when it or its affiliates decide to sell. Investors must make all investment decisions based on their own judgment of the market and the particular securities.

This advertorial contains forward-looking statements that involve risks and uncertainties. This advertorial contains or incorporates by reference forward-looking statements, including certain information with respect to plans and strategies of the featured company. As such, any statements contained herein or incorporated herein by reference that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believe(s),” “anticipate(s),” “plan(s),” “expect(s),” “project(s),” “will,” “make,” “told,” “could,” “might,” and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause actual events or actual results of the company to differ materially from these indicated by such forward-looking statements. Certain statements contained herein are forward-looking statements as defined in Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Such statements include, without limitation, statements regarding business, financing, business trends, future operating revenues and expenses. There can be no assurance that such expectations will prove to be correct. Investors are cautioned that any forward-looking statements made by the company, or contained in this advertorial are not guarantees of future performance, and that the issuer’s actual results may differ materially from those set forth in the forward-looking statements. We undertake no obligation to update any statements made herein except as required by law. Differences in results can be caused by various factors including, but not limited to, the company’s ability to be able to successfully complete planned funding agreements, to successfully market its products in competitive industries or to effectively implement its business plan or strategies. To reiterate, information presented in this advertorial contains “forward-looking statements.” Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be “forward-looking statements.” Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. More information on the company may be found at http://www.sec.gov where readers can review all public filings submitted by the company. PsychedelicStockWatch.com is not a certified financial analyst or licensed in the securities industry in any manner. The information in this advertorial is subjective opinion and may not be complete, accurate or current and was paid for, so this could create a conflict of interest.

 
© 2019 - 2021 Psychedelic Stock Watch, Privacy Policy, Disclaimer